Comparison of clinical outcome between Ticagrelor and Prasugrel in patient with ST-Segment Elevation Myocardial Infarction : Korea Acute Myocardial Infarction Registry-National Institutes of Health
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2018
Price : $35 *
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 19 Apr 2018 New trial record
- 12 Apr 2018 Primary endpoint (Major adverse cardiac events (MACE), has not been met, according to results published in the Circulation Journal.
- 12 Apr 2018 Results published in the Circulation Journal.